OpenFederal grantOpen to for-profit businessesRFA-AI-28-024

Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)

National Institutes of HealthCloses Feb 11, 2027(120 days left)

Does this fit your business?

This NIH program funds research and preclinical development of highly effective malaria vaccines, intended as a model for other mosquito-borne diseases. It is for organizations already doing vaccine or immunology R&D, such as biotech firms, universities, and research nonprofits. If your business is not in vaccine research, or you need money for clinical trials or foreign subawards, do not apply.

Best for
Biotech and vaccine R&D companies, Universities and research institutes, Nonprofits doing immunology or vaccine research, Government and tribal research entities
Not for
Businesses outside vaccine or immunology R&D, Projects involving clinical trials, Applicants planning foreign subawards or subcontracts
Estimated fit by industry, best first
IndustryEstimated fit
Healthcare & BiotechMatches your industry (health, clinical)
79
Strong Match
Technology & SoftwareMatches your industry (tech, innovation)
73
Good Match
Arts & CultureLimit: Nothing in this notice points to arts & culture
54
Possible Match
Energy & Clean TechLimit: Nothing in this notice points to energy & clean tech
54
Possible Match
Environment & ConservationLimit: Nothing in this notice points to environment & conservation
54
Possible Match
Housing & Real EstateLimit: Not clearly about your industry or what you need funding for; check the…
54
Possible Match
Show all 15 industries
Estimated fit by industry, best first
IndustryEstimated fit
Social Services & NonprofitLimit: Not clearly about your industry or what you need funding for; check the…
54
Possible Match
Education & TrainingLimit: Nothing in this notice points to education & training
53
Possible Match
Food & BeverageLimit: Nothing in this notice points to food & beverage
53
Possible Match
Agriculture & FarmingLimit: Nothing in this notice points to agriculture & farming
52
Possible Match
ManufacturingLimit: Nothing in this notice points to manufacturing
52
Possible Match
Construction & InfrastructureLimit: Nothing in this notice points to construction & infrastructure
49
Possible Match
Finance & BankingLimit: Nothing in this notice points to finance & banking
49
Possible Match
Retail & E-CommerceLimit: Nothing in this notice points to retail & e-commerce
49
Possible Match
Transportation & LogisticsLimit: Nothing in this notice points to transportation & logistics
49
Possible Match

These are our matcher’s estimates for a typical business in each industry. A real match depends on your size, your state and what you need the money for — check your own fit.

What this funds

Money can be used for
Research, R&D
Who can apply
Small businesses, For-profit companies, Nonprofits, State and local governments, Tribal governments and organizations, Colleges and universities, Other applicants (see eligibility)

Questions about this grant

When is the application deadline?
The application deadline is 2027-02-11.
How much funding can an applicant receive?
Total program funding is $4,000,000. The amount an individual applicant can receive is not published.
Who can apply for this grant?
Small businesses, other for-profit organizations, nonprofits with or without 501(c)(3) status, public and private institutions of higher education, state, county, city, and special district governments, tribal governments and tribal organizations, public housing authorities, independent school districts, and foreign organizations can apply. Applications involving foreign subawards or subcontracts will be deemed noncompliant and not considered.
Can a nonprofit apply?
Yes. Both nonprofits with 501(c)(3) status and nonprofits without 501(c)(3) status are eligible, as are institutions of higher education.

Summary

NIH funds research and preclinical development of next-generation malaria vaccines (clinical trials not allowed), leveraging structure-based immunogen design, improved formulations, and combination vaccines to protect against malaria and other mosquito-borne diseases. Small businesses, for-profits, nonprofits, universities, state/local/tribal governments, and foreign organizations may apply; no外国

About this grant

The purpose of this notice of funding opportunity (NOFO) is to support research and/or preclinical development of highly efficacious vaccines against malaria - one of the deadliest mosquito-borne diseases - by capitalizing on recent technological innovations, particularly in structure-based immunogen design, improved formulations, and combination vaccines. The goal is to achieve long-lasting, highly effective protection that can save lives, strengthen public health security in the United States, and serve as a model for, or are potentially effective against, other mosquito-borne diseases.

Who can apply

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibilityForeign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.

Topics and uses of funds

Topics

  • Health
  • Science

Program contact

National Institutes of HealthMalariaandOtherMosquitoBorneDiseases@mail.nih.gov301-402-2541

Related grants

Open opportunities funding similar work, from the same funder or in the same place.

All grantsGrants by stateGrants by industry